Personalis Total Assets 2018-2025 | PSNL
Personalis total assets from 2018 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Personalis Annual Total Assets
(Millions of US $) |
| 2024 |
$270 |
| 2023 |
$225 |
| 2022 |
$293 |
| 2021 |
$397 |
| 2020 |
$245 |
| 2019 |
$157 |
| 2018 |
$42 |
| 2017 |
$0 |
Personalis Quarterly Total Assets
(Millions of US $) |
| 2025-03-31 |
$273 |
| 2024-12-31 |
$270 |
| 2024-09-30 |
$240 |
| 2024-06-30 |
$186 |
| 2024-03-31 |
$195 |
| 2023-12-31 |
$225 |
| 2023-09-30 |
$227 |
| 2023-06-30 |
$249 |
| 2023-03-31 |
$272 |
| 2022-12-31 |
$293 |
| 2022-09-30 |
$318 |
| 2022-06-30 |
$358 |
| 2022-03-31 |
$381 |
| 2021-12-31 |
$397 |
| 2021-09-30 |
$407 |
| 2021-06-30 |
$383 |
| 2021-03-31 |
$396 |
| 2020-12-31 |
$245 |
| 2020-09-30 |
$249 |
| 2020-06-30 |
$146 |
| 2020-03-31 |
$152 |
| 2019-12-31 |
$157 |
| 2019-09-30 |
$160 |
| 2019-06-30 |
$192 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$0 |
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| 2017-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.415B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
